RVL Pharmaceuticals plc OSMT
Set alert
1.11 0.00 0.00%
At close
1.09 Day range 1.15
52-week range unavailable
- Open
- 1.14
- Prev close
- 1.11
- Mkt cap
- 110.18M
- Vol
- 296.32K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.09
- High
- 1.15
- Forward P/E
- -1.59
- Beta
- 1.96
- Short ratio
- 0.53
- Inst. own
- 35.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 15, 2021
- 50-d avg
- 1.15
- 200-d avg
- 2.48
- 1y target
- 5.75
Analyst view
Consensus: buy
Buy
Price target (mean) 5.75 +418.0% upside
Now 1.11
- Target (low)
- 5.00
- Target (mean)
- 5.75
- Target (high)
- 7.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.28 | -0.31 – -0.26 | -0.88 | +68.2% | 3.60M | -89.6% | 3 |
| Next quarter | -0.25 | -0.25 – -0.25 | -0.15 | -66.7% | 6.71M | -71.9% | 1 |
| Current year | -1.03 | -1.30 – -0.82 | -1.31 | +21.4% | 18.61M | -89.5% | 3 |
| Next year | -0.70 | -0.72 – -0.68 | -1.03 | +32.0% | 55.57M | +198.6% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 23, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 24, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 17, 2021 | RBC Capital | Maintained | — | Outperform |
| Jul 10, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Jul 10, 2020 | SVB Leerink | Maintained | — | Outperform |
| Mar 6, 2020 | SVB Leerink | Initiated | — | Outperform |